TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 3 | 7 | 2 | -4 | -27 | -4 |
| S | %wins | 100 | 0 | 0 | 0 | 100 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/7/09 18:10 | 4/3/09 | STEM | Stemcells Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Martin M | CA | DO | P,CEO | M.d | 54 | 0.9400 | 0 | 57 | 26 | 275 | D | -42 | 10 | 70 | 13 | -13 | -1 | -2 | 2 | 0 | 3 | 7 | 2 | -4 | -27 |
4/7/09 18:10 | 4/3/09 | STEM | Stemcells Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Martin M | CA | DO | P,CEO | S.d | -241 | 1.66 | 0 | -145 | -35 | 275 | D | -42 | 10 | 70 | 13 | -13 | -1 | -2 | 2 | 0 | 3 | 7 | 2 | -4 | -27 |
1/9/07 12:31 | 1/8/07 | STEM | Stemcells Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Martin M | CA | DO | P,CEO | M.d | 648 | 2.22 | 0 | 292 | 0 | D | -37 | 1 | 57 | 65 | 11 | 23 | 39 | 32 | -2 | -11 | -18 | -18 | -30 | -58 | |
10/27/06 15:02 | 10/27/06 | STEM | Stemcells Inc | DE | Health | BioPrd | Biological Products, (No Diag | McGlynn Martin M | CA | DO | P,CEO | M.d | 382 | 1.97 | 0 | 194 | 0 | D | -16 | -42 | 7 | 34 | 23 | 22 | 3 | -3 | 6 | 8 | 5 | 4 | -11 | -21 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |